Alternating PSMA Expression Levels by Ionizing Radiation Exposure as an Additional Feature in PSMA-Targeting Prostate Cancer Treatment: First In Vitro Evaluation

被引：0
|
作者：
Arbuznikova, D. [1 ,2 ,3 ]
Boll, M. [1 ,2 ,4 ]
Grosu, A. [3 ,5 ]
Meyer, P. T. [1 ,5 ]
Eder, M. [1 ,2 ,4 ]
Zamboglou, C. [3 ,5 ]
Eder, A. [1 ,2 ,4 ]
机构：
[1] Univ Med Ctr Freiburg, Dept Nucl Med, Freiburg, Germany
[2] German Canc Consortium DKTK, Partner Site Freiburg, Div Radiopharmaceut Dev, Freiburg, Germany
[3] Univ Med Ctr Freiburg, Dept Radiat Oncol, Freiburg, Germany
[4] German Canc Res Ctr, Heidelberg, Germany
[5] German Canc Consortium DKTK, Partner Site Freiburg, Freiburg, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-0195
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 28 条
  • [21] PRECLINICAL ACTIVITY AND SAFETY PROFILE OF JANX007, A NOVEL PSMA-TARGETING TUMORACTIVATED T CELL ENGAGER FOR TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    DiRaimondo, Thomas
    Budimir, Natalija
    Shenhav, Simon
    Wu, Hua
    Cicchini, Vanessa
    Jocic, Renee
    Ma, Lina
    Roup, Fabrece
    Campbell, Calvin
    Caffaro, Carolina
    Aerni, Hans
    Eskiocak, Ugur
    Godfrey, Wayne
    Winter, Charles
    Nasoff, Marc
    Gibson, Neil
    Campbell, David
    Salek-Ardakani, Shahram
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1376 - A1376
  • [22] 177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry
    Abouzayed, Ayman
    Seitova, Kamila
    Lundmark, Fanny
    Bodenko, Vitalina
    Oroujeni, Maryam
    Tolmachev, Vladimir
    Rosenstrom, Ulrika
    Orlova, Anna
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [23] Development and preclinical evaluation of biodistribution and dosimetry of 177Lu-labelled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer
    Orlova, A.
    Abouzayed, A.
    Seitova, K.
    Lundmark, F.
    Bodenko, V.
    Oroujeni, M.
    Tolmachev, V.
    Rosenstrom, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S335 - S335
  • [24] Preclinical evaluation and first in human study of Al18F radiolabeled ODAP-urea-based PSMA targeting ligand for PET imaging of prostate cancer
    Ren, Ya'nan
    Liu, Chen
    Liu, Teli
    Duan, Xiaojiang
    Zhang, Qian
    Liu, Jiayue
    Wang, Pei
    Guo, Qian
    Yang, Xing
    Du, Peng
    Zhu, Hua
    Yang, Zhi
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
    Christian M. Zechmann
    Ali Afshar-Oromieh
    Tom Armor
    James B. Stubbs
    Walter Mier
    Boris Hadaschik
    John Joyal
    Klaus Kopka
    Jürgen Debus
    John W. Babich
    Uwe Haberkorn
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 1280 - 1292
  • [26] Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
    Zechmann, Christian M.
    Afshar-Oromieh, Ali
    Armor, Tom
    Stubbs, James B.
    Mier, Walter
    Hadaschik, Boris
    Joyal, John
    Kopka, Klaus
    Debus, Juergen
    Babich, John W.
    Haberkorn, Uwe
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (07) : 1280 - 1292
  • [27] First-in-human phase I study of HPN424, a tri-specific half-life extended PSMA-targeting T-cell engager in patients with metastatic castration-resistant prostate cancer (mCRPC).
    Bendell, Johanna C.
    Fong, Lawrence
    Stein, Mark N.
    Beer, Tomasz M.
    Ross, Ashley
    Gao, Xin
    Weitzman, Aaron
    Austin, Richard
    Ganti, Vaishnavi
    Law, Che-Leung
    Lemon, Bryan
    Wesche, Holger
    De Bono, Johann S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Comparison of novel PSMA-targeting [177Lu]Lu-P17-087 with its albumin binding derivative [177Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study
    Li, Linlin
    Wang, Jiarou
    Wang, Guochang
    Wang, Rongxi
    Jin, Wenbin
    Zang, Jie
    Sui, Huimin
    Jia, Chenhao
    Jiang, Yuanyuan
    Hong, Haiyan
    Zhu, Lin
    Alexoff, David
    Ploessl, Karl
    Kung, Hank F.
    Zhu, Zhaohui
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (09) : 2794 - 2805
123